Compare EPM & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EPM | STXS |
|---|---|---|
| Founded | 2003 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.9M | 190.6M |
| IPO Year | 1996 | 2004 |
| Metric | EPM | STXS |
|---|---|---|
| Price | $4.16 | $1.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $4.83 | $4.00 |
| AVG Volume (30 Days) | 324.3K | ★ 347.1K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | ★ 10.08% | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,229,621.00 | $29,346,617.00 |
| Revenue This Year | N/A | $28.22 |
| Revenue Next Year | N/A | $30.47 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.19 | $1.70 |
| 52 Week High | $5.70 | $3.59 |
| Indicator | EPM | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 43.19 | 45.99 |
| Support Level | $4.13 | $1.73 |
| Resistance Level | $4.63 | $1.99 |
| Average True Range (ATR) | 0.14 | 0.09 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 26.92 | 22.86 |
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.